Early palliative care may boost quality of life in advanced GI cancers
NCT ID NCT02246725
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study looked at whether early contact with a palliative care unit improves quality of life for people with advanced cancers of the upper gastrointestinal tract or colorectal cancer. 108 participants were randomly assigned to either early palliative care or standard care (contact when needed). The researchers measured quality of life, anxiety, and survival. The goal is to see if starting palliative care earlier makes a meaningful difference for patients and their families.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- What this could lead to
- If it works, this could show that early palliative care improves quality of life and possibly survival for people with advanced gastrointestinal cancers.
- What could go wrong
- This is a small, completed study with 108 participants. The results may not apply to all cancer types or stages, and the intervention is supportive care, not a treatment for the cancer itself.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Lund University Hospital
Lund, 221 85, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a plasma beam stop colon polyps from coming back?
- A stitch in time: could a device make abdominal closure safer?
- Can we predict chemo brain before it happens?
- Your gut bacteria might reveal hidden cancer risk
- Can a smart digital program restore sleep for cancer survivors?
- Can a new infusion drug shrink Hard-to-Treat tumors?